Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001140361-25-044950
Filing Date
2025-12-09
Accepted
2025-12-09 09:24:28
Documents
1
Effectiveness Date
2025-12-09

Document Format Files

Seq Description Document Type Size
1 POSASR ef20060810_posasr.htm POSASR 21016
  Complete submission text file 0001140361-25-044950.txt   22078
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-279338 | Film No.: 251557787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)